Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma.
暂无分享，去创建一个
Sonali M. Smith | R. Fisher | Y. Oki | E. Ross | E. Dulaimi | R. Alpaugh | J. Ruan | K. Campbell | S. Barta | H. Fung | J. Zain | Yibin Yang | N. Fowler | N. Khan | C. Tan | A. Macfarlane | Rawat Siddharta | A. MacFarlane | Essel Dulaimi | Stefan K. Barta